These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11706702)

  • 1. Prothrombin cleaving antibody light chains.
    Thiagarajan P; Paul S
    Chem Immunol; 2000; 77():115-29. PubMed ID: 11706702
    [No Abstract]   [Full Text] [Related]  

  • 2. Lupus-derived antiprothrombin autoantibodies from a V gene phage display library are specific for the kringle 2 domain of prothrombin.
    Le A; Dasgupta S; Planque S; Paul S; Thiagarajan P
    Biochemistry; 2004 Apr; 43(13):4047-54. PubMed ID: 15049712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complexes of anti-prothrombin antibodies and prothrombin cause lupus anticoagulant activity by competing with the binding of clotting factors for catalytic phospholipid surfaces.
    Simmelink MJ; Horbach DA; Derksen RH; Meijers JC; Bevers EM; Willems GM; De Groot PG
    Br J Haematol; 2001 Jun; 113(3):621-9. PubMed ID: 11380447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of the light chain for the epitope specificity of human anti-U1 small nuclear RNA autoantibodies present in systemic lupus erythematosus patients.
    Hoet RM; Pieffers M; Stassen MH; Raats J; de Wildt R; Pruijn GJ; van den Hoogen F; van Venrooij WJ
    J Immunol; 1999 Sep; 163(6):3304-12. PubMed ID: 10477600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody light chain with prothrombinase activity.
    Thiagarajan P; Dannenbring R; Matsuura K; Tramontano A; Gololobov G; Paul S
    Biochemistry; 2000 May; 39(21):6459-65. PubMed ID: 10828960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catalytic activity of antibody light chain to gp41: a consideration of refolding in relation to activation mechanism.
    Uda T; Hifumi E; Ohara K; Zhou Y
    Chem Immunol; 2000; 77():18-32. PubMed ID: 11706704
    [No Abstract]   [Full Text] [Related]  

  • 7. Autoantibody catalysis: no longer hostage to Occam's razor.
    Paul S
    Ann N Y Acad Sci; 1998 Dec; 865():238-46. PubMed ID: 9928017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural catalytic immunity is not restricted to autoantigenic substrates: identification of a human immunodeficiency virus gp 120-cleaving antibody light chain.
    Paul S; Kalaga RS; Gololobov G; Brenneman D
    Appl Biochem Biotechnol; 2000; 83(1-3):71-82; discussion 82-4, 145-53. PubMed ID: 10826950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward selective covalent inactivation of pathogenic antibodies: a phosphate diester analog of vasoactive intestinal peptide that inactivates catalytic autoantibodies.
    Nishiyama Y; Bhatia G; Bangale Y; Planque S; Mitsuda Y; Taguchi H; Karle S; Paul S
    J Biol Chem; 2004 Feb; 279(9):7877-83. PubMed ID: 14676184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homology of the NH2-terminal amino acid sequences of the heavy and light chains of human monoclonal lupus autoantibodies containing the dominant 16/6 idiotype.
    Atkinson PM; Lampman GW; Furie BC; Naparstek Y; Schwartz RS; Stollar BD; Furie B
    J Clin Invest; 1985 Apr; 75(4):1138-43. PubMed ID: 3921567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiolipin binding a light chain from lupus-prone mice.
    Pereira B; Benedict CR; Le A; Shapiro SS; Thiagarajan P
    Biochemistry; 1998 Feb; 37(5):1430-7. PubMed ID: 9477972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate antibody catalysis.
    Gololobov G; Sun M; Paul S
    Mol Immunol; 1999 Dec; 36(18):1215-22. PubMed ID: 10684961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of protease activity in antibody subunits.
    Sun M; Li L; Gao QS; Paul S
    Ann N Y Acad Sci; 1995 Sep; 764():573-5. PubMed ID: 7486588
    [No Abstract]   [Full Text] [Related]  

  • 14. Substrate-driven formation of a proteolytic antibody light chain.
    Gao QS; Sun M; Tyutyulkova S; Webster D; Rees A; Tramontano A; Massey RJ; Paul S
    Ann N Y Acad Sci; 1995 Sep; 764():567-9. PubMed ID: 7486586
    [No Abstract]   [Full Text] [Related]  

  • 15. Factor VIII inhibitor with catalytic activity towards factor VIII.
    Lacroix-Desmazes S; Sooryanarayana ; Moreau A; Horn MP; Kazatchkine MD; Kaveri SV
    Chem Immunol; 2000; 77():102-14. PubMed ID: 11706701
    [No Abstract]   [Full Text] [Related]  

  • 16. Improvement of catalytic antibody activity by protease processing.
    Ohara K; Munakata H; Hifumi E; Uda T; Matsuura K
    Biochem Biophys Res Commun; 2004 Mar; 315(3):612-6. PubMed ID: 14975745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Existence of IgA-antiprothrombin antibody in a patient with systemic lupus erythematosus.
    Matsuda J; Sanaka T; Yoshida M; Gotoh M; Gohchi K
    Eur J Haematol; 2002 Aug; 69(2):126-7. PubMed ID: 12366720
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationship between clinical features and binding domains of anti-prothrombin autoantibodies in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Akimoto T; Akama T; Kono I; Sumida T
    Lupus; 1999; 8(9):761-6. PubMed ID: 10602450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA-hydrolyzing autoantibodies in autoimmune pathologies.
    Schourov DV; Gololobov GV; Makarevich OI; Yadav RP; Chernova EA; Nevinsky GA; Prokaeva TB; Alekberova ZS; Gabibov AG
    Ann N Y Acad Sci; 1995 Mar; 750():255-64. PubMed ID: 7785851
    [No Abstract]   [Full Text] [Related]  

  • 20. How and why 41S-2 antibody subunits acquire the ability to catalyze decomposition of the conserved sequence of gp41 of HIV-1.
    Hifumi E; Okamoto Y; Uda T
    Appl Biochem Biotechnol; 2000; 83(1-3):209-19; discussion 219-20, 297-313. PubMed ID: 10826961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.